Total Payments
$41,942
2024 Payments
$27,803
Companies
3
Transactions
45
Medicare Patients
5,639
Medicare Billing
$2.6M
Payment Breakdown by Category
Consulting$38,630 (92.1%)
Travel$2,659 (6.3%)
Food & Beverage$653.29 (1.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,630 | 18 | 92.1% |
| Travel and Lodging | $2,659 | 16 | 6.3% |
| Food and Beverage | $653.29 | 11 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $33,969 | 41 | $0 (2024) |
| Janssen Global Services, LLC | $7,920 | 2 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $53.29 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,803 | 14 | Janssen Pharmaceuticals, Inc ($27,750) |
| 2023 | $6,219 | 29 | Janssen Pharmaceuticals, Inc ($6,219) |
| 2021 | $2,880 | 1 | Janssen Global Services, LLC ($2,880) |
| 2020 | $5,040 | 1 | Janssen Global Services, LLC ($5,040) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| 11/25/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| 07/29/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $370.00 | General |
| 07/29/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $370.00 | General |
| 07/29/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $370.00 | General |
| 07/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: UROLOGY | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| 06/18/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| 06/18/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| 06/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: UROLOGY | ||||||
| 02/07/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $4,440.00 | General |
| 02/07/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $4,440.00 | General |
| 02/07/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $4,440.00 | General |
| 02/07/2024 | Janssen Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $4,440.00 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $129.32 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $129.32 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $129.32 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $129.32 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 12/10/2023 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 12/09/2023 | Janssen Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $196.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,050 | 4,063 | $1.5M | $562,210 |
| 2022 | 14 | 1,572 | 3,103 | $1.7M | $680,109 |
| 2021 | 18 | 1,742 | 3,588 | $1.9M | $786,413 |
| 2020 | 18 | 1,275 | 2,614 | $1.5M | $608,838 |
Total Patients
5,639
Total Services
13,368
Medicare Billing
$2.6M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 76 | 594 | $891,000 | $410,043 | 46.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 12 | 1,860 | $118,500 | $53,959 | 45.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 88 | 291 | $229,704 | $31,644 | 13.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 228 | 315 | $66,231 | $21,303 | 32.2% |
| 92134 | Imaging of retina | Office | 2023 | 284 | 626 | $104,604 | $20,142 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 56 | $16,532 | $5,519 | 33.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 93 | 94 | $18,412 | $4,732 | 25.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 29 | 32 | $14,264 | $3,476 | 24.4% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 27 | 30 | $14,154 | $3,195 | 22.6% |
| 92274 | Measurement of retinal and optic nerve function targeting multiple separate locations | Office | 2023 | 37 | 37 | $10,069 | $2,635 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $6,920 | $2,448 | 35.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 14 | 14 | $4,294 | $1,521 | 35.4% |
| 92250 | Photography of the retina | Office | 2023 | 39 | 39 | $9,162 | $1,105 | 12.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 39 | 40 | $2,232 | $489.14 | 21.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 77 | 766 | $1.1M | $548,521 | 47.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 86 | 350 | $236,615 | $37,562 | 15.9% |
| 92134 | Imaging of retina | Office | 2022 | 389 | 804 | $120,600 | $25,381 | 21.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 274 | 346 | $65,200 | $21,328 | 32.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 95 | 99 | $26,829 | $9,330 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 94 | $21,620 | $8,946 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 88 | $15,701 | $6,408 | 40.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 45 | 49 | $19,657 | $5,264 | 26.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 89 | 105 | $16,876 | $5,011 | 29.7% |
| 92274 | Measurement of retinal and optic nerve function targeting multiple separate locations | Office | 2022 | 40 | 44 | $10,560 | $3,353 | 31.8% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2022 | 25 | 26 | $9,100 | $2,655 | 29.2% |
About Mandeep Singh
Mandeep Singh is a Ophthalmology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1851747752.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mandeep Singh has received a total of $41,942 in payments from pharmaceutical and medical device companies, with $27,803 received in 2024. These payments were reported across 45 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($38,630).
As a Medicare-enrolled provider, Singh has provided services to 5,639 Medicare beneficiaries, totaling 13,368 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Baltimore, MD
- Active Since 05/10/2016
- Last Updated 05/10/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1851747752
Products in Payments
- GEMTESA (Drug) $53.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Baltimore
Dr. Alfred Sommer, M.d, M.D
Ophthalmology — Payments: $3.7M
Ophthalmology $3.7M
Peter Mcdonnell
Ophthalmology — Payments: $2.2M
Ophthalmology $2.2M
Esen Akpek, M.d, M.D
Ophthalmology — Payments: $627,113
Ophthalmology $627,113
Neil Bressler, M.d, M.D
Ophthalmology — Payments: $524,415
Ophthalmology $524,415
Peter Campochiaro, M.d, M.D
Ophthalmology — Payments: $257,471
Ophthalmology $257,471
Jennifer Thorne, M.d, M.D
Ophthalmology — Payments: $201,745
Ophthalmology $201,745